Dutch okays mutant bird flu study's publication
April 27, 2012 in Medical research
The Dutch government on Friday gave a top scientist the green light to publish a research paper in the United States on a mutant killer flu virus, following approval by a US panel of experts.
"Deputy Minister Henk Bleker approved a permit for the publication of the research done by professor Ron Fouchier on the H5N1 bird flu virus," his spokeswoman Cindy Heijdra told AFP.
Dutch approval comes after a panel of US science and security experts last month said two papers on the deadly flu should be published in the US-based Science journal, reversing an earlier decision to withhold key details.
Fouchier had to get permission first from the Dutch Department of Economic Affairs, Agriculture and Innovation -- in line with EU regulations -- because a risk existed that the H5N1 virus, as well as its research, "could be used for the wrong purposes", the Dutch department said in a statement.
"The minister gave the go-ahead after considering the risks and advantages of publishing the paper including the freedom of science and publication, national health and security," his spokeswoman Heijdra added.
Fouchier's team at Rotterdam's Erasmus Medical Centre last year announced the mutant version which showed how an engineered H5N1 flu virus could pass easily in the air between ferrets. A second team based in Wisconsin came to the same conclusion.
But US experts previously opposed publishing the research over fears it could fall into the wrong hands and unleash a deadly flu epedemic.
Bird flu is believed to kill more than half the people it infects, making it much more lethal than typical strains of the seasonal virus.
According to the World Health Organisation, there have been at least 573 cases of H5N1 bird flu in humans in 15 countries since 2003, with 58.6 percent of those resulting in death.
(c) 2012 AFP
-
Mutant bird flu 'less lethal', says paper's author
Apr 03, 2012 |
not rated yet |
0
-
World vigilant after Dutch lab mutates killer virus
Dec 09, 2011 |
not rated yet |
0
-
Killer flu virus threat over-hyped: Dutch scientist
Dec 21, 2011 |
not rated yet |
0
-
U.S. gives green light to publish controversial bird flu research
Apr 23, 2012 |
not rated yet |
0
-
Divides emerge in US, world response to mutant flu
Feb 29, 2012 |
not rated yet |
0
-
Motion perception revisited: High Phi effect challenges established motion perception assumptions
Apr 23, 2013 |
3 / 5 (2) |
2
-
Anything you can do I can do better: Neuromolecular foundations of the superiority illusion (Update)
Apr 02, 2013 |
4.5 / 5 (11) |
5
-
The visual system as economist: Neural resource allocation in visual adaptation
Mar 30, 2013 |
5 / 5 (2) |
9
-
Separate lives: Neuronal and organismal lifespans decoupled
Mar 27, 2013 |
4.9 / 5 (8) |
0
-
Sizing things up: The evolutionary neurobiology of scale invariance
Feb 28, 2013 |
4.8 / 5 (10) |
14
-
Pressure-volume curve: Elastic Recoil Pressure don't make sense
May 18, 2013
-
If you became brain-dead, would you want them to pull the plug?
May 17, 2013
-
MRI bill question
May 15, 2013
-
Ratio of Hydrogen of Oxygen in Dessicated Animal Protein
May 13, 2013
-
Alcohol and acetaminophen
May 13, 2013
-
Marie Curie's leukemia
May 13, 2013
- More from Physics Forums - Medical Sciences
More news stories
Computational tool translates complex data into simplified 2-dimensional images
In their quest to learn more about the variability of cells between and within tissues, biomedical scientists have devised tools capable of simultaneously measuring dozens of characteristics of individual ...
Medical research
2 hours ago |
5 / 5 (1) |
0
|
Now we know why old scizophrenia medicine works on antibiotics-resistant bacteria
In 2008 researchers from the University of Southern Denmark showed that the drug thioridazine, which has previously been used to treat schizophrenia, is also a powerful weapon against antibiotic-resistant bacteria such as ...
Medical research
May 17, 2013 |
3.7 / 5 (3) |
0
|
SUMO wrestling cells reveal new protective mechanism target for stroke
Scientists investigating the interaction of a group of proteins in the brain responsible for protecting nerve cells from damage have identified a new target that could increase cell survival.
Medical research
May 17, 2013 |
5 / 5 (1) |
0
How serotonin receptors can shape drug effects, from LSD to migraine medication
New findings by researchers carrying out experiments at the U.S. Department of Energy Office of Science's Advanced Photon Source (APS) help explain why some drugs that interact with two kinds of human serotonin ...
Medical research
May 17, 2013 |
4 / 5 (1) |
0
|
Preventing blood poisoning
Peptide molecules derived from the body's natural immune system can help boost the body's defence against life-threatening blood poisoning, joint University research has uncovered.
Medical research
May 17, 2013 |
4 / 5 (1) |
0
|
Researchers identify a potential new risk for sleep apnea: Asthma
Researchers at the University of Wisconsin have identified a potential new risk factor for obstructive sleep apnea: asthma. Using data from the National Institutes of Health (Heart, Lung, and Blood Institute)-funded Wisconsin ...
Study finds that sleep apnea and Alzheimer's are linked
A new study looking at sleep-disordered breathing (SDB) and markers for Alzheimer's disease (AD) risk in cerebrospinal fluid (CSF) and neuroimaging adds to the growing body of research linking the two.
New theory on genesis of osteoarthritis comes with successful therapy in mice
Scientists at Johns Hopkins have turned their view of osteoarthritis (OA) inside out. Literally. Instead of seeing the painful degenerative disease as a problem primarily of the cartilage that cushions joints, ...
Ginger compounds may be effective in treating asthma symptoms
Gourmands and foodies everywhere have long recognized ginger as a great way to add a little peppery zing to both sweet and savory dishes; now, a study from researchers at Columbia University shows purified components of the ...
'Gap' for HIV vaccine efforts after latest setback
The hunt for an HIV vaccine has gobbled up $8 billion in the past decade, and the failure of the most recent efficacy trial has delivered yet another setback to 26 years of efforts.
Alzheimer's leaves bilingual victims stranded in Canada
The devastating effect of Alzheimer's disease on bilingual people has been thrown into focus in Canada, where the sudden loss of a second language can leave sufferers feeling like strangers in their own country.
Apr 27, 2012
Rank: not rated yet